JPRN-UMIN000005797已完成未知
Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis - Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis
Department of Neurology, Tohoku University School of Medicine0 个研究点目标入组 100 人开始时间: 2011年6月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
5% of the patients with interferon-beta-1a and 10% of the patients with interferon-beta-1b revealed to have high titer of neutralizing antibody and seemed to be influenced to clinical course.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
eutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation - NAb development with RNFIFNß-naïve patients fulfilling Poser or McDonald criteria for CDMS or MS and in whom a decision has been made to initiate treatment with RNF (Rebif New Formulation).MedDRA version: 9.1Level: LLTClassification code 10028245Term: Multiple sclerosisEUCTR2008-008554-23-SEThe Multiple Sclerosis Research Group, Department of Clinical Neuroscience100
已完成
不适用
A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisMultiple SclerosisNCT00288990Biogen300
招募中
不适用
eutralizing antibody of Interferon beta on multiple sclerosis (Multi-center clinical studies)Multiple sclerosisJPRN-UMIN000008186Yokohama City University100
进行中（未招募）
不适用
Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy - Interferon beta dose and antibodyMultiple sclerosisEUCTR2005-001008-37-SESahlgrenska University Hospital100
已完成
Unknown
Changes in specific antibody titers and interferon gamma levels after a BNT162b2 vaccine boosterCOVID-19JPRN-UMIN000048810Fukuoka City Hospital400